Active allies: Hormones, stem cells and the niche in adult mammopoiesis

Trends in Endocrinology and Metabolism

Volumn 23, Issue 6, 2012, Pages 299-309

  Joshi, Purna A ^a,b   Di Grappa, Marco A ^a   Khokha, Rama ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hormones; Mammary stem cells; Progesterone; Stem cell niche

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA6 INTEGRIN; ATAXIN 1; BETA1 INTEGRIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CD24 ANTIGEN; CYTOKERATIN 14; CYTOKERATIN 5; ESTROGEN; ESTROGEN RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROLACTIN; PROTEIN P63; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; WNT4 PROTEIN;

ADULT STEM CELL; BREAST CANCER; BREAST CELL; CANCER RISK; CELL CYCLE PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL RENEWAL; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; HEMATOPOIETIC STEM CELL; HORMONE SUBSTITUTION; HUMAN; LUTEAL PHASE; MAMMARY GLAND; MAMMARY STEM CELL NICHE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; REPRODUCTION; REVIEW; STEM CELL EXPANSION; STEM CELL NICHE; TISSUE GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; GONADAL STEROID HORMONES; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MODELS, ANIMAL; RISK FACTORS; STEM CELL NICHE; STEM CELLS;

EID: 84861686065     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.04.002     Document Type: Review

References (99)

1. Watson C.J., Khaled W.T. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 2008, 135:995-1003.
2. Woodward W.A., et al. On mammary stem cells. J. Cell. Sci. 2005, 118:3585-3594.
3. Stingl J., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
4. Shackleton M., et al. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
5. Sleeman K.E., et al. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J. Cell Biol. 2007, 176:19-26.
6. Stingl J., et al. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 2001, 67:93-109.
7. Eirew P., et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat. Med. 2008, 14:1384-1389.
8. Asselin-Labat M.L., et al. Steroid hormone receptor status of mouse mammary stem cells. J. Natl. Cancer Inst. 2006, 98:1011-1014.
9. Lim E., et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 2010, 12:R21.
10. Raouf A., et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008, 3:109-118.
11. LaBarge M.A., et al. Of microenvironments and mammary stem cells. Stem Cell Rev. 2007, 3:137-146.
12. Li L., Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 2006, 66:4553-4557.
13. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4(1-2):7-25.
14. Crittenden S.L., et al. Cellular analyses of the mitotic region in the Caenorhabditis elegans adult germ line. Mol. Biol. Cell 2006, 17:3051-3061.
15. Xie T., Spradling A.C. A niche maintaining germ line stem cells in the Drosophila ovary. Science 2000, 290:328-330.
16. Kiger A.A., et al. Somatic support cells restrict germline stem cell self-renewal and promote differentiation. Nature 2000, 407:750-754.
17. Crittenden S.L., et al. A conserved RNA-binding protein controls germline stem cells in Caenorhabditis elegans. Nature 2002, 417:660-663.
18. Adams G.B., Scadden D.T. The hematopoietic stem cell in its place. Nat. Immunol. 2006, 7:333-337.
19. Calvi L.M., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
20. Potten C.S., et al. The intestinal epithelial stem cell: the mucosal governor. Int. J. Exp. Pathol. 1997, 78:219-243.
21. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 2008, 40:915-920.
22. Barker N., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
23. Gregorieff A., et al. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 2005, 129:626-638.
24. Voog J., Jones D.L. Stem cells and the niche: a dynamic duo. Cell Stem Cell 2010, 6:103-115.
25. Greco V., et al. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell 2009, 4:155-169.
26. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
27. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
28. Kiefer J.C. Primer and interviews: the dynamic stem cell niche. Dev. Dyn. 2011, 240:737-743.
29. Smalley M.J., et al. Clonal characterization of mouse mammary luminal epithelial and myoepithelial cells separated by fluorescence-activated cell sorting. In Vitro Cell. Dev. Biol. Anim. 1998, 34:711-721.
30. Richert M.M., et al. An atlas of mouse mammary gland development. J. Mammary Gland Biol. Neoplasia 2000, 5:227-241.
31. Howard B.A., Gusterson B.A. Human breast development. J. Mammary Gland Biol. Neoplasia 2000, 5:119-137.
32. Deome K.B., et al. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 1959, 19:515-520.
33. Smith G.H. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res. Treat. 1996, 39:21-31.
34. Kordon E.C., Smith G.H. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998, 125:1921-1930.
35. Stingl J., et al. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 1998, 63:201-213.
36. Gudjonsson T., et al. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 2002, 16:693-706.
37. Smith G.H., Medina D. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J. Cell Sci. 1988, 90:173-183.
38. Van Keymeulen A., et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193.
39. Welm B.E., et al. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 2002, 245:42-56.
40. Smith G.H. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005, 132:681-687.
41. Bai L., Rohrschneider L.R. s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev. 2010, 24:1882-1892.
42. Taddei I., et al. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat. Cell Biol. 2008, 10:716-722.
43. Lim E., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913.
44. Daniel C.W., et al. The in vivo life span of normal and preneoplastic mouse mammary glands: a serial transplantation study. Proc Natl. Acad. Sci. U.S.A. 1968, 61:53-60.
45. Villadsen R., et al. Evidence for a stem cell hierarchy in the adult human breast. J. Cell Biol. 2007, 177:87-101.
46. Winkler I.G., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.
47. Gyorki D.E., et al. Resident macrophages influence stem cell activity in the mammary gland. Breast Cancer Res. 2009, 11:R62.
48. Sternlicht M.D. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res. 2006, 8:201.
49. Williams J.M., Daniel C.W. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 1983, 97:274-290.
50. Walden P.D., et al. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 1998, 139:659-662.
51. Ciarloni L., et al. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5455-5460.
52. Lee D.C., et al. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann. N. Y. Acad. Sci. 2003, 995:22-38.
53. Sternlicht M.D., et al. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 2005, 132:3923-3933.
54. Wiesen J.F., et al. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 1999, 126:335-344.
55. Oakes S.R., et al. The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Res. 2006, 8:207.
56. Asselin-Labat M.L., et al. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802.
57. Wagner K.U., et al. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 2002, 129:1377-1386.
58. Matulka L.A., et al. Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. Dev. Biol. 2007, 303:29-44.
59. Boulanger C.A., et al. Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3871-3876.
60. Booth B.W., et al. The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14891-14896.
61. Hawkins S.M., Matzuk M.M. The menstrual cycle: basic biology. Ann. N. Y. Acad. Sci. 2008, 1135:10-18.
62. Fata J.E., et al. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell. Mol. Life Sci. 2000, 57:77-95.
63. Joshi P.A., et al. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807.
64. Haslam S.Z., Shyamala G. Effect of oestradiol on progesterone receptors in normal mammary glands and its relationship with lactation. Biochem. J. 1979, 182:127-131.
65. Beleut M., et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2989-2994.
66. Graham J.D., et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 2009, 150:3318-3326.
67. Brisken C., et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000, 14:650-654.
68. Mulac-Jericevic B., et al. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:9744-9749.
69. Fata J.E., et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000, 103:41-50.
70. Mukherjee A., et al. Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB J. 2010, 24:4408-4419.
71. Badders N.M., et al. The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS ONE 2009, 4:e6594.
72. Duheron V., et al. Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5342-5347.
73. Mikkola M.L. Genetic basis of skin appendage development. Semin. Cell Dev. Biol. 2007, 18:225-236.
74. Kariagina A., et al. Progesterone receptor isoforms and proliferation in the rat mammary gland during development. Endocrinology 2007, 148:2723-2736.
75. Aupperlee M.D., Haslam S.Z. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 2007, 148:2290-2300.
76. Aupperlee M.D., et al. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 2005, 146:3577-3588.
77. Lydon J.P., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995, 9:2266-2278.
78. Kelsey J.L., et al. Reproductive factors and breast cancer. Epidemiol. Rev. 1993, 15:36-47.
79. Al-Hajj M., et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3983-3988.
80. Kauff N.D., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 2002, 346:1609-1615.
81. Lambe M., et al. Transient increase in the risk of breast cancer after giving birth. N. Engl. J. Med. 1994, 331:5-9.
82. Albrektsen G., et al. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br. J. Cancer 2005, 92:167-175.
83. Guzman R.C., et al. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2520-2525.
84. Smith G.H. Stem cells, hormones, and mammary cancer. Adv. Exp. Med. Biol. 2008, 617:69-78.
85. Henry M.D., et al. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 2004, 23:6980-6985.
86. Jernstrom H., et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 1999, 354:1846-1850.
87. Lydon J.P., et al. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999, 59:4276-4284.
88. Poole A.J., et al. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 2006, 314:1467-1470.
89. King T.A., et al. Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers. Cancer Res. 2004, 64:5051-5053.
90. Sartorius C.A., et al. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res. 2005, 65:9779-9788.
91. Boecker W., Buerger H. Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif. 2003, 36(Suppl. 1):73-84.
92. Forbes J.F., et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008, 9:45-53.
93. Rice L.W. Hormone prevention strategies for breast, endometrial and ovarian cancers. Gynecol. Oncol. 2010, 118:202-207.
94. Rossouw J.E., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
95. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427.
96. Schramek D., et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010, 468:98-102.
97. Gonzalez-Suarez E., et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 2010, 468:103-107.
98. Santini D., et al. Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. PLoS ONE 2011, 6:e19234.
99. Tan W., et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 2011, 470:548-553.